PRECIGEN, INC. Proceeds from Long-Term Debt Issued
PRECIGEN, INC. (PGEN) reported Proceeds from Long-Term Debt Issued of $92.82 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-03-25
- PRECIGEN, INC. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was -$654.00K.
- PRECIGEN, INC. proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $0.00.
- PRECIGEN, INC. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- PRECIGEN, INC. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- PRECIGEN, INC. proceeds from issuance of long-term debt for fiscal 2025 was $92.82M.
- PRECIGEN, INC. proceeds from issuance of long-term debt for fiscal 2024 was $0.00.
- PRECIGEN, INC. proceeds from issuance of long-term debt for fiscal 2023 was $0.00.
- PRECIGEN, INC. proceeds from issuance of long-term debt for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $92.82M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $93.47M 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-25 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $376.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $376.00K 10-Q · filed 2020-11-09 | $26.23M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $376.00K 10-Q · filed 2020-08-10 | $26.23M derived: sum of 3 quarters · filed 2021-03-01 | $220.24M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $376.00K 10-Q · filed 2020-05-11 | $26.23M derived: sum of 2 quarters · filed 2021-03-01 | $220.24M derived: sum of 3 quarters · filed 2021-03-01 | $220.24M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $25.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $219.86M derived: sum of 2 quarters · filed 2021-03-01 | $219.86M derived: sum of 3 quarters · filed 2021-03-01 | $219.86M 10-K · filed 2021-03-01 |
| 2018-09-30 | $194.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $194.00M derived: sum of 2 quarters · filed 2019-11-12 | $194.00M 10-Q · filed 2019-11-12 | $194.04M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $40.00K derived: sum of 3 quarters · filed 2020-03-02 | $40.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $40.00K derived: sum of 2 quarters · filed 2020-03-02 | $40.00K derived: sum of 3 quarters · filed 2020-03-02 | $199.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $40.00K derived: sum of 2 quarters · filed 2020-03-02 | $199.00K derived: sum of 3 quarters · filed 2020-03-02 | $325.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $159.00K derived: sum of 2 quarters · filed 2018-11-08 | $285.00K 10-Q · filed 2018-11-08 | $285.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $159.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $285.00K 10-Q · filed 2018-08-13 | $285.00K derived: sum of 3 quarters · filed 2019-03-01 | $832.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $126.00K 10-Q/A · filed 2018-08-13 | $126.00K derived: sum of 2 quarters · filed 2019-03-01 | $673.00K derived: sum of 3 quarters · filed 2019-03-01 | $673.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $547.00K derived: sum of 2 quarters · filed 2019-03-01 | $547.00K derived: sum of 3 quarters · filed 2019-03-01 | $547.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $547.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $547.00K derived: sum of 2 quarters · filed 2017-11-09 | $547.00K 10-Q · filed 2017-11-09 | $547.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $37.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $37.00K derived: sum of 3 quarters · filed 2018-03-01 | $37.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $37.00K derived: sum of 2 quarters · filed 2018-03-01 | $37.00K derived: sum of 3 quarters · filed 2018-03-01 | $81.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $37.00K derived: sum of 2 quarters · filed 2016-11-09 | $81.00K 10-Q · filed 2016-11-09 | $81.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $44.00K 10-Q · filed 2016-08-09 | $44.00K derived: sum of 3 quarters · filed 2017-03-01 | $44.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $44.00K 10-Q · filed 2016-05-10 | $44.00K derived: sum of 2 quarters · filed 2017-03-01 | $44.00K derived: sum of 3 quarters · filed 2017-03-01 | $164.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $120.00K derived: sum of 3 quarters · filed 2017-03-01 | $268.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $120.00K derived: sum of 2 quarters · filed 2015-11-09 | $268.00K 10-Q · filed 2015-11-09 | $407.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $268.00K 10-Q · filed 2015-08-10 | $407.00K derived: sum of 3 quarters · filed 2016-02-29 | $590.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $148.00K 10-Q · filed 2015-05-11 | $287.00K derived: sum of 2 quarters · filed 2016-02-29 | $470.00K derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $322.00K derived: sum of 2 quarters · filed 2016-02-29 | $493.00K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $354.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $171.00K 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |